Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

45.53 -0.77 (-1.66%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 320,702
Open 46.33
Bid (Size) 45.08 (300)
Ask (Size) 47.91 (3,100)
Prev. Close 46.30
Today's Range 45.06 - 46.46
52wk Range 23.23 - 50.79
Shares Outstanding 32,250,236
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Collegium Announces the Closing of $980 Million Syndicated Credit Facility
Five-Year Financing with Favorable Terms that Significantly Reduce Interest Rate 
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
2 Reasons to Avoid COLL and 1 Stock to Buy Instead
Collegium Pharmaceutical has been on fire lately. In the past six months alone, the company’s stock price has rocketed 68.7%, setting a new 52-week high of $49.89 per share. This was partly thanks to... 
Via StockStory
Topics Supply Chain

Performance

YTD
N/A
N/A
1 Month
-4.2%
-4.2%
3 Month
+32.8%
+32.8%
6 Month
+50.0%
+50.0%
1 Year
+59.0%
+59.0%

More News

Read More
News headline image
3 Cash-Producing Stocks We Think Twice About
Via StockStory
News headline image
Earnings Scheduled For November 6, 2025 ↗
Via Benzinga
News headline image
Collegium Pharmaceutical Inc (NASDAQ:COLL) Shows Strong Earnings Momentum and Bullish Technical Setup ↗
Via Chartmill
News headline image
3 Unpopular Stocks We Find Risky
Via StockStory
News headline image
Collegium Pharmaceutical Inc (NASDAQ:COLL) Fits the Minervini Growth Momentum Strategy ↗
Via Chartmill
News headline image
Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL)
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
1 Growth Stock Set to Flourishand 2 Facing Challenges
Via StockStory
News headline image
1 Mooning Stock with Promising Prospects and 2 Facing Challenges
Via StockStory
News headline image
1 Small-Cap Stock with Exciting Potential and 2 We Avoid
Via StockStory
News headline image
Branded Pharmaceuticals Stocks Q3 Earnings: Eli Lilly (NYSE:LLY) Best of the Bunch
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Collegium Pharmaceutical Inc (NASDAQ:COLL) Shows High Growth Momentum with Strong Technicals ↗
Via Chartmill
News headline image
5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q3 Earnings Call
Via StockStory
Topics Earnings
News headline image
1 Safe-and-Steady Stock with Competitive Advantages and 2 We Brush Off
Via StockStory
News headline image
Collegium to Participate in Upcoming Investor Conferences
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
2 Momentum Stocks with Exciting Potential and 1 We Find Risky
Via StockStory
Topics Credit Cards
News headline image
COLL Q3 Deep Dive: Jornay PM Momentum and Pain Portfolio Drive Upgraded Outlook
Via StockStory
News headline image
Why Are Collegium Pharmaceutical (COLL) Shares Soaring Today
Via StockStory
Topics Economy Government World Trade
News headline image
Collegium Pharmaceutical Inc (NASDAQ:COLL) Beats Q3 2025 Estimates and Raises Full-Year Guidance ↗
Via Chartmill
News headline image
Collegium Pharmaceutical (NASDAQ:COLL) Delivers Impressive Q3, Stock Jumps 12.1%
Via StockStory
News headline image
Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Earnings To Watch: Collegium Pharmaceutical (COLL) Reports Q3 Results Tomorrow
Via StockStory
News headline image
3 Stocks Under $50 That Fall Short
Via StockStory
Topics Artificial Intelligence
News headline image
Paris Hilton Collaborates with Collegium Pharmaceutical to Share Her Personal ADHD Journey and Experience with Treatment
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Collegium Pharmaceutical, Inc. - Common Stock publicly traded?
Yes, Collegium Pharmaceutical, Inc. - Common Stock is publicly traded.
What exchange does Collegium Pharmaceutical, Inc. - Common Stock trade on?
Collegium Pharmaceutical, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock?
The ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock is COLL on the Nasdaq Stock Market
What is the current price of Collegium Pharmaceutical, Inc. - Common Stock?
The current price of Collegium Pharmaceutical, Inc. - Common Stock is 45.53
When was Collegium Pharmaceutical, Inc. - Common Stock last traded?
The last trade of Collegium Pharmaceutical, Inc. - Common Stock was at 01/02/26 04:00 PM ET
What is the market capitalization of Collegium Pharmaceutical, Inc. - Common Stock?
The market capitalization of Collegium Pharmaceutical, Inc. - Common Stock is 1.47B
How many shares of Collegium Pharmaceutical, Inc. - Common Stock are outstanding?
Collegium Pharmaceutical, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.